YPYuliia Protsenko

Yuliia Protsenko

*This is an algorithmically generated author record based on publicly available information.

Yuliia Protsenko has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dietary supplements for sports enthusiasts - effective support or the impact of marketing campaigns? A narrative review

    by Paula Hauzer, Aleksandra Kaniak, Julianna Zielska, Yuliia Protsenko, Kacper Forszt, Julia Andrzejewska

    Introduction and objective: Dietary supplements are becoming increasingly popular, especially among physically active people, regardless of their level of experience. In Poland, as many as 90% of adults use such products, which highlights their importance in everyday life. The reasons for using supplements are varied, ranging from actual health needs to the influence of intensive marketing. Given the huge number of products available and insufficient market supervision, it is crucial to understand the principles of their use. The aim of this study is to assess the validity of supplementation among physically active people in the context of real health needs and the impact of marketing on consumer decisions. Abbreviated description of the state of knowledge: Supplements are products that supplement the diet and contain concentrated ingredients with physiological effects. Unlike drugs, they do not undergo rigorous clinical trials. They are often used without consulting experts, and knowledge about them comes mainly from advertising and the media. The Australian Institute of Sport (AIS) has divided supplements into four groups, A-D, according to their effectiveness and safety. Professional athletes usually seek the help of specialists, while amateurs often choose supplements on their own, which carries a risk of error. Products that support recovery, performance, and concentration are particularly popular. Social media, through influential celebrities, often promote unverified information. Summary: Supplements can support the health of physically active people, but their use should be informed and consulted with specialists. Excessive trust in advertising and a lack of knowledge increase the risk of misuse of these products. Education, legal regulations, and professional advice are key to safe supplementation.

  • Open Access

    Non-Suicidal Self-Injury (NSSI) in Borderline Personality Disorder: Dynamic Mechanisms, Cascading Models, and Psychosocial Outcomes in the Context of Specialist Interventions

    by Yuliia Protsenko, Magdalena Barczewska, Anna Marczak, Marta Kowalska, Dominika Bieszczad, Zuzanna Musialska, Olga Stadnicka, Marta Opalińska-Kubowicz, Marzena Swojnóg, Adam Mazurek, et al.

    Background. Non-suicidal self-injury (NSSI) occurs in 69-90% of women with borderline personality disorder (BPD) and represents a critical diagnostic criterion and therapeutic challenge. Despite its high prevalence and clinical significance, the dynamic psychological and neurobiological mechanisms underlying NSSI remain incompletely understood, and a substantial gap persists between acute symptom reduction and long-term psychosocial recovery. Aim. This study reviews NSSI in BPD, focusing on: identification of proximal psychological mechanisms and developmental factors influencing NSSI risk, and assessment of specialized therapeutic approaches' effectiveness in reducing NSSI and achieving sustained psychosocial functioning. Materials and Methods. A literature review was conducted using databases (PubMed, PsycINFO, and Google Scholar) for articles up to November 2025. Inclusion criteria focused on peer-reviewed studies examining NSSI in BPD populations using validated assessment tools. Results. Neuroimaging demonstrates that NSSI produces immediate amygdala deactivation, providing neurobiological reinforcement for this behavior. The Emotional Cascade Model identifies rumination instability and emotion differentiation deficits as key triggers for NSSI episodes. Childhood trauma dysregulates the HPA axis and correlates with functional deficits. Dialectical Behavior Therapy (DBT) shows a moderate effect size in reducing self-harm (Hedges' g = -0.622) and induces neuroplastic changes. Mentalization-Based Therapy (MBT) reduces suicide attempts, though social functioning often remains impaired even in long-term follow-up. Conclusions. Specialized psychotherapies effectively stabilize acute symptoms, but a clear gap persists between symptom control and functional recovery. Future research should adopt complex dynamic systems perspectives and prioritize outcomes reflecting social integration and quality of life.

  • Open Access

    Therapeutic potential of curcumin in dermatological conditions: mechanisms, clinical evidence and safety considerations

    by Olga Stadnicka, Kinga Popielarska, Marta Opalińska-Kubowicz, Zuzanna Musialska, Yuliia Protsenko, Marta Kowalska, Magdalena Barczewska, Anna Marczak, Dominika Bieszczad, Marzena Swojnóg, et al.

    Curcumin, a pleiotropic polyphenol derived from Curcuma longa, has gained considerable interest as a potential adjuvant therapy in dermatology due to its anti-inflammatory, antioxidant, antimicrobial and immunomodulatory properties. Preclinical studies demonstrate that curcumin modulates key molecular pathways involved in skin disease, including NF-κB, JAK–STAT, MAPK and Nrf2 signalling, affecting keratinocytes, fibroblasts, melanocytes, sebocytes and cutaneous immune cells. These findings have led to an increasing number of clinical studies investigating oral and topical curcumin, novel formulations and photodynamic applications across various dermatological conditions, such as psoriasis, atopic dermatitis, acne, pigmentary disorders, chronic wounds and photoaging. Clinical evidence suggests potential benefit as an adjunct to standard therapy in psoriasis, inflammatory and pruritic dermatoses, limited vitiligo and selected wound-healing settings, while data for cosmetic and infectious indications remain preliminary. Overall, curcumin shows a favourable safety profile, with mostly mild gastrointestinal or local adverse effects, though emerging reports of hepatotoxicity and drug interactions warrant caution with high-dose or long-term systemic use. Its clinical translation is limited by poor bioavailability, heterogeneous formulations, small and methodologically weak trials and lack of outcome standardisation. This narrative review summarises current mechanistic and clinical evidence, highlights limitations and identifies priorities for future research to better define curcumin’s role in modern dermatology.

  • Open Access

    Paediatric Stroke: Diagnostic Strategies and Therapeutic Dillemas

    by Dominika Bieszczad, Magdalena Barczewska, Adam Mazurek, Kinga Popielarska, Marta Opalińska-Kubowicz, Zuzanna Musialska, Yuliia Prostenko, Marta Kowalska, Anna Marczak, Olga Stadnicka, et al.

    Background. Paediatric arterial ischemic stroke is a potentially disabling neurological condition that remains underrecognized due to its rarity and atypical clinical presentation. Diagnosis in children is often delayed because of heterogeneous symptoms and differences in stroke mechanisms compared with adults. Despite advances in neuroimaging and acute reperfusion therapies, evidence-based paediatric-specific diagnostic and treatment strategies remain limited. Aim. This review aimed to summarise current evidence regarding the epidemiology, pathophysiology, diagnostic approach, and management of acute ischemic stroke in the paediatric population. Material and methods. A narrative review of the literature was conducted using structured searches of PubMed, Google Scholar, and clinical guideline repositories. Articles published between 2015 and 2025 were included, comprising original studies, systematic reviews, meta-analyses, and international clinical guidelines focusing on risk factors, clinical presentation, neuroimaging, acute treatment, and secondary prevention. Results. Paediatric stroke differs substantially from adult stroke in etiology, clinical features, and outcomes. The most common causes include cerebral arteriopathies, congenital heart disease, infections, and haematological disorders such as sickle cell disease. Magnetic resonance imaging is the diagnostic modality of choice, with diffusion-weighted imaging and vessel wall imaging improving diagnostic accuracy. Intravenous thrombolysis and mechanical thrombectomy may be feasible and relatively safe in selected paediatric patients; however, high-quality evidence remains limited. Conclusion. Paediatric ischemic stroke remains a diagnostic and therapeutic challenge. Delayed recognition and heterogeneous mechanisms continue to limit optimal management. Further studies are needed to develop evidence-based paediatric guidelines and improve acute and long-term outcomes.

  • Open Access

    THE DAWN PHENOMENON AND GLYCEMIC VARIABILITY MEASURED WITH CONTINUOUS GLUCOSE MONITORING

    by Marzena Swojnóg, Kinga Popielarska, Marta Opalińska-Kubowicz, Zuzanna Musialska, Yuliia Protsenko, Marta Kowalska, Magdalena Barczewska, Anna Marczak, Dominika Bieszczad, Olga Stadnicka, et al.

    The dawn phenomenon (DP), defined as an early-morning rise in glucose unrelated to preceding nocturnal hypoglycemia, represents a significant yet often underrecognized contributor to fasting hyperglycemia and overall glycemic instability in individuals with diabetes. The expansion of continuous glucose monitoring (CGM) technologies over the past decade has enabled more precise characterization of nocturnal glucose patterns, offering new insights into the prevalence, magnitude, and clinical implications of DP across diverse glycemic states. This review synthesizes original observational, retrospective, and prospective studies published between 2010 and 2025 that used CGM to evaluate DP in type 1 diabetes, type 2 diabetes, impaired glucose tolerance, and non-diabetic populations. Data extraction focused on DP definitions, nocturnal glucose trajectories, glycemic variability metrics, associations with HbA1c and time-in-range, and emerging evidence linking severe DP to adverse clinical outcomes. Findings indicate that DP is highly prevalent in both type 1 and type 2 diabetes, with magnitude varying widely depending on residual β-cell function, insulin sensitivity, and methodological differences in CGM-based definitions. DP correlates with increased total glucose exposure and greater glycemic variability, and may influence long-term metabolic risk. Understanding DP within the context of CGM-derived metrics is essential for optimizing individualized therapeutic strategies and improving morning glycemic control. Further standardized research is required to unify definitions and clarify the prognostic significance of DP.

  • Open Access

    GLOBAL LONGITUDINAL STRAIN AND 3D ECHOCARDIOGRAPHY FOR EARLY DETECTION OF ANTHRACYCLINE-INDUCED SUBCLINICAL CARDIOTOXICITY: NARRATIVE REVIEW

    by Marta Kowalska, Kinga Popielarska, Marta Opalińska-Kubowicz, Zuzanna Musialska, Yuliia Protsenko, Magdalena Barczewska, Anna Marczak, Dominika Bieszczad, Olga Stadnicka, Marzena Swojnóg, et al.

    Introduction and purpose: Anthracyclines are highly effective chemotherapeutic agents but carry a significant risk of dose-dependent cardiac toxicity, often progressing silently before left-ventricular ejection fraction (LVEF) declines. The objective of this review was to evaluate the role of three-dimensional echocardiography (3D-ECHO) and global longitudinal strain (GLS) in the early detection of subclinical anthracycline-induced cardiotoxicity and to compare their diagnostic performance with conventional 2D-LVEF assessment. Methods: A narrative review was conducted using clinical and observational studies indexed in PubMed over the last ten years. Only peer-reviewed human research evaluating anthracycline-induced cardiotoxicity was included. Studies comparing 2D-LVEF with 3D-LVEF and/or global longitudinal strain (GLS), as well as those assessing early markers of subclinical left-ventricular dysfunction, were selected. Extracted data focused on diagnostic effectiveness, time-to-detection of myocardial injury, and prognostic relevance of strain-based parameters. Conclusion: GLS and 3D-echocardiography outperform conventional 2D-LVEF in identifying early, subclinical anthracycline-related cardiotoxicity. GLS provides the highest sensitivity for early myocardial injury, while 3D-STE enhances spatial assessment and detects dysfunction before EF decline. Routine integration of these modalities into cardio-oncology surveillance may enable earlier intervention, prevent irreversible damage, and improve long-term cardiac outcomes.

  • Open Access

    How obesity impacts the skin microbiome - Literature review

    by Marta Opalińska-Kubowicz, Kinga Popieralska, Zuzanna Musialska, Yuliia Protsenko, Marta Kowalska, Magdalena Barczewska, Dominika Bieszczad, Anna Marczak, Olga Stadnicka, Marzena Swojnóg, et al.

    Background. Obesity is becoming an increasingly serious problem in society and affects an entire human body including skin. It potentially affects barrier integrity, immune responses and susceptibility to dermatoses. Aim. This review aims to examine how obesity changes the composition and function of the skin microbiome and what are the possible consequences. Material and methods. A research was performed in the PubMed and Google Scholar based on peer-reviewed studies published between 2017 – 2025 and focusing on phrases “skin microbiome”, “obesity”, and “skin diseases”. Results. Available studies indicate reduced microbial diversity, increased colonisation by opportunistic pathogens and overgrowth of yeasts on the skin of obese patients. Mechanical factors such as friction, sweating and elevated skin-fold temperature promote dysbiosis and inflammation. These changes are associated with dermatoses such as atopic dermatitis, intertrigo, folliculitis, seborrhoeic dermatitis and hidradenitis suppurativa. Treatment strategies include weight reduction, targeted skincare, antimicrobial treatment and new microbiome-modulating therapies. Conclusions. Obesity significantly influences the skin microbiome, contributing to a higher risk of infections and inflammatory dermatoses. Although the understanding of these mechanisms is improving, further research, particularly involving metagenomics and metabolomics is needed to develop more precise preventive and therapeutic approaches.

  • Open Access

    How obesity impacts the skin microbiome - Literature review

    by Marta Opalińska-Kubowicz, Kinga Popieralska, Zuzanna Musialska, Yuliia Protsenko, Marta Kowalska, Magdalena Barczewska, Dominika Bieszczad, Anna Marczak, Olga Stadnicka, Marzena Swojnóg, et al.

    Background. Obesity is becoming an increasingly serious problem in society and affects an entire human body including skin. It potentially affects barrier integrity, immune responses and susceptibility to dermatoses. Aim. This review aims to examine how obesity changes the composition and function of the skin microbiome and what are the possible consequences. Material and methods. A research was performed in the PubMed and Google Scholar based on peer-reviewed studies published between 2017 – 2025 and focusing on phrases “skin microbiome”, “obesity”, and “skin diseases”. Results. Available studies indicate reduced microbial diversity, increased colonisation by opportunistic pathogens and overgrowth of yeasts on the skin of obese patients. Mechanical factors such as friction, sweating and elevated skin-fold temperature promote dysbiosis and inflammation. These changes are associated with dermatoses such as atopic dermatitis, intertrigo, folliculitis, seborrhoeic dermatitis and hidradenitis suppurativa. Treatment strategies include weight reduction, targeted skincare, antimicrobial treatment and new microbiome-modulating therapies. Conclusions. Obesity significantly influences the skin microbiome, contributing to a higher risk of infections and inflammatory dermatoses. Although the understanding of these mechanisms is improving, further research, particularly involving metagenomics and metabolomics is needed to develop more precise preventive and therapeutic approaches.